TD Cowen maintains Calumet at Hold, lowers price target to $37 from $40
TD Cowen kept its Hold rating on Calumet but reduced its price target from $40 to $37, a 7.5% cut. This new target suggests a 16.3% upside from the Nov 17 closing price of $31.82, according to the firm.
How this was made

The 30-second read
Why it matters
A lower price target can shift near-term sentiment and expectations, but the unchanged Hold rating suggests the analyst does not see a strong catalyst for a directional re-rating.
Market read
Useful for traders tracking sell-side sentiment, but it is not a standalone fundamental catalyst.
What to watch
Traders may already price in analyst target changes; without new operational data, the impact may fade quickly unless other firms issue similar downgrades.
Background
The piece is an analyst action update from TD Cowen on Calumet, not a company disclosure.
Ticker impact
TD Cowen maintained Calumet at Hold and cut its price target to $37 from $40, implying a lower valuation for CLMT.
Likely mild downward pressure or reduced upside expectations as the market digests the lower target, with limited follow-through risk given the unchanged Hold.
The article provides a specific, time-relevant analyst action (PT cut) but no new company fundamentals or catalyst beyond the rating update.
Market effects
Minimal, as this is a single-name analyst target change with no sector-wide catalyst described.
None indicated.
None indicated.
Counterpoint
Because the rating stays at Hold, the PT cut may be more about valuation than a new deterioration in fundamentals, limiting downside follow-through.
Key entities
- companyCalumet
Subject of the analyst action, with a Hold rating and a reduced price target.
- analyst_firmTD Cowen
Brokerage issuing the maintained rating and lowered target.

